NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine Care

Clinical trial NCT07424261 · RECRUITING

Trial details

NCT number: NCT07424261
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Lupus Erythematosus, Systemic

Start date: 2026-03-19
Primary completion: 2029-08-31
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.